MTOR and cyst: This may be important from a therapeutic perspective: the mTOR pathway has been considered as a drug target in arresting ADPKD progression, despite recent studies in humans with ADPKD that did not demonstrate a therapeutic effect of Sirolimus and Everolimus, inhibitors of the mTOR pathway, on cyst progression [42,43].